Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
The Rhythms of the Street: Shipping's Tune in the Economy's Symphony - 2What do teens and tweens want for the holidays? E-bikes, gift cards and lip tints.
- 3The Best Cell phone Brands for Tech Lovers
- 4Which Film Has the Incomparable Melodic Score?
- 5The Fate of Gaming: 5 Energizing Advancements Not too far off
- Am I a Summer, or is this a scam? What I learned from color analysis.
- The 15 Best Business visionaries Under 40
- Muslim Brotherhood stole half a billion dollars in Gaza donations, Arab sources reveal
- From School Dropout to Example of overcoming adversity: My Excursion
- Exploring the School Application Cycle: Understudy Bits of knowledge
- Experts who once backed 'shaken baby' science now fight to free imprisoned caregivers
- What to know about MIT professor Nuno Loureiro and the investigation into his shooting
- From Lounge chair to Money: Online Positions That Will Change Your Profession
- How to watch 'A Charlie Brown Christmas' for free in 2025
